Rishab Gupta, B.M.,B.S., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Crime | 2 | 2014 | 215 | 0.830 |
Why?
|
Endarterectomy, Carotid | 1 | 2023 | 546 | 0.650 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2021 | 503 | 0.640 |
Why?
|
Child Abuse, Sexual | 1 | 2020 | 383 | 0.620 |
Why?
|
Fluoxetine | 1 | 2021 | 749 | 0.610 |
Why?
|
Hypoglycemia | 2 | 2022 | 861 | 0.600 |
Why?
|
Carotid Artery Diseases | 1 | 2023 | 882 | 0.590 |
Why?
|
Meditation | 1 | 2019 | 242 | 0.560 |
Why?
|
Carotid Stenosis | 1 | 2023 | 854 | 0.550 |
Why?
|
Substance Abuse Treatment Centers | 2 | 2019 | 168 | 0.550 |
Why?
|
Lumbosacral Region | 1 | 2017 | 310 | 0.540 |
Why?
|
Stereotyping | 2 | 2018 | 241 | 0.520 |
Why?
|
Depressive Disorder, Major | 4 | 2021 | 4644 | 0.520 |
Why?
|
Tranquilizing Agents | 1 | 2014 | 59 | 0.500 |
Why?
|
Product Labeling | 1 | 2015 | 79 | 0.480 |
Why?
|
Antipsychotic Agents | 4 | 2017 | 3057 | 0.450 |
Why?
|
Substance-Related Disorders | 3 | 2019 | 4258 | 0.440 |
Why?
|
Opiate Substitution Treatment | 2 | 2018 | 404 | 0.440 |
Why?
|
Ocular Motility Disorders | 1 | 2014 | 135 | 0.440 |
Why?
|
Violence | 2 | 2015 | 909 | 0.400 |
Why?
|
Stroke | 2 | 2023 | 9981 | 0.380 |
Why?
|
Conduct Disorder | 1 | 2012 | 241 | 0.370 |
Why?
|
Narcotics | 1 | 2012 | 343 | 0.360 |
Why?
|
Methadone | 1 | 2012 | 306 | 0.360 |
Why?
|
Telephone | 1 | 2012 | 617 | 0.340 |
Why?
|
School Health Services | 1 | 2012 | 375 | 0.330 |
Why?
|
Obsessive-Compulsive Disorder | 2 | 2017 | 1444 | 0.330 |
Why?
|
Prejudice | 1 | 2013 | 570 | 0.330 |
Why?
|
Students, Medical | 3 | 2018 | 1862 | 0.330 |
Why?
|
Lumbar Vertebrae | 1 | 2017 | 1848 | 0.320 |
Why?
|
Opioid-Related Disorders | 4 | 2019 | 2065 | 0.310 |
Why?
|
Psychotic Disorders | 2 | 2019 | 3046 | 0.300 |
Why?
|
Child Behavior Disorders | 1 | 2012 | 807 | 0.300 |
Why?
|
Schizophrenia | 3 | 2021 | 6882 | 0.280 |
Why?
|
Burnout, Professional | 1 | 2015 | 694 | 0.280 |
Why?
|
Smoking Cessation | 2 | 2016 | 2071 | 0.280 |
Why?
|
Interpersonal Relations | 1 | 2012 | 1425 | 0.250 |
Why?
|
India | 8 | 2019 | 2197 | 0.240 |
Why?
|
Gliclazide | 1 | 2022 | 4 | 0.210 |
Why?
|
Mental Health | 2 | 2015 | 3019 | 0.210 |
Why?
|
Patient Compliance | 1 | 2012 | 2684 | 0.200 |
Why?
|
Smoking | 2 | 2016 | 8987 | 0.200 |
Why?
|
Mental Disorders | 2 | 2017 | 6600 | 0.180 |
Why?
|
Butorphanol | 1 | 2018 | 12 | 0.160 |
Why?
|
Opium | 1 | 2018 | 29 | 0.160 |
Why?
|
Head | 1 | 2023 | 880 | 0.160 |
Why?
|
Bipolar Disorder | 3 | 2021 | 5027 | 0.150 |
Why?
|
Schizophrenia, Paranoid | 1 | 2017 | 104 | 0.150 |
Why?
|
Community Health Services | 2 | 2019 | 650 | 0.140 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2017 | 295 | 0.140 |
Why?
|
Primary Health Care | 1 | 2012 | 4558 | 0.140 |
Why?
|
Subarachnoid Space | 1 | 2015 | 79 | 0.130 |
Why?
|
Humans | 31 | 2023 | 744343 | 0.130 |
Why?
|
House Calls | 1 | 2016 | 160 | 0.130 |
Why?
|
Delusions | 1 | 2017 | 300 | 0.130 |
Why?
|
Oligopeptides | 1 | 2020 | 1189 | 0.130 |
Why?
|
Mentally Ill Persons | 1 | 2015 | 126 | 0.130 |
Why?
|
Third Ventricle | 1 | 2015 | 76 | 0.120 |
Why?
|
Plant Extracts | 1 | 2018 | 471 | 0.120 |
Why?
|
Puerperal Disorders | 1 | 2017 | 275 | 0.120 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2020 | 1205 | 0.120 |
Why?
|
Ventriculostomy | 1 | 2015 | 136 | 0.120 |
Why?
|
Dilatation, Pathologic | 1 | 2015 | 520 | 0.120 |
Why?
|
Mesencephalon | 1 | 2015 | 329 | 0.110 |
Why?
|
Male | 18 | 2021 | 350118 | 0.110 |
Why?
|
Bulimia Nervosa | 1 | 2014 | 177 | 0.110 |
Why?
|
Prisoners | 1 | 2015 | 297 | 0.110 |
Why?
|
Stents | 1 | 2023 | 3280 | 0.100 |
Why?
|
Lactones | 1 | 2014 | 329 | 0.100 |
Why?
|
Terminology as Topic | 1 | 2018 | 1547 | 0.100 |
Why?
|
Anti-Obesity Agents | 1 | 2014 | 217 | 0.090 |
Why?
|
Sexual Behavior | 1 | 2020 | 2057 | 0.090 |
Why?
|
Brain | 1 | 2017 | 26385 | 0.090 |
Why?
|
Behavior, Addictive | 1 | 2015 | 462 | 0.090 |
Why?
|
Hypoglycemic Agents | 2 | 2022 | 2872 | 0.080 |
Why?
|
Hydrocephalus | 1 | 2015 | 748 | 0.080 |
Why?
|
Female | 15 | 2021 | 380194 | 0.080 |
Why?
|
Patient Acceptance of Health Care | 2 | 2019 | 3022 | 0.080 |
Why?
|
Young Adult | 7 | 2019 | 56430 | 0.070 |
Why?
|
Veterans | 1 | 2021 | 2519 | 0.070 |
Why?
|
Antihypertensive Agents | 1 | 2016 | 2046 | 0.070 |
Why?
|
Public Health | 2 | 2015 | 2603 | 0.060 |
Why?
|
Suicide | 1 | 2015 | 1477 | 0.060 |
Why?
|
Adaptation, Psychological | 1 | 2015 | 2576 | 0.060 |
Why?
|
Adult | 13 | 2022 | 214055 | 0.060 |
Why?
|
Middle Aged | 8 | 2022 | 213383 | 0.060 |
Why?
|
Pregnancy Complications | 1 | 2017 | 2861 | 0.060 |
Why?
|
Algorithms | 1 | 2023 | 13881 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2015 | 2291 | 0.050 |
Why?
|
Internet | 1 | 2015 | 3064 | 0.050 |
Why?
|
Risk Factors | 4 | 2023 | 72290 | 0.050 |
Why?
|
Risk Assessment | 1 | 2023 | 23338 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2018 | 3674 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12261 | 0.050 |
Why?
|
Anxiety | 1 | 2015 | 4297 | 0.050 |
Why?
|
Hypertension | 2 | 2019 | 8480 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2015 | 4245 | 0.050 |
Why?
|
Comorbidity | 1 | 2014 | 10388 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2023 | 63114 | 0.040 |
Why?
|
Nitrazepam | 1 | 2018 | 2 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12959 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 5751 | 0.040 |
Why?
|
Heroin Dependence | 1 | 2019 | 175 | 0.040 |
Why?
|
GABA Modulators | 1 | 2018 | 107 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 11725 | 0.040 |
Why?
|
Drug Combinations | 1 | 2022 | 1959 | 0.040 |
Why?
|
Cardiovascular Diseases | 2 | 2019 | 15165 | 0.030 |
Why?
|
Naltrexone | 1 | 2018 | 307 | 0.030 |
Why?
|
Croatia | 1 | 2015 | 35 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2018 | 1420 | 0.030 |
Why?
|
Depression | 1 | 2015 | 7766 | 0.030 |
Why?
|
Community Mental Health Centers | 1 | 2015 | 102 | 0.030 |
Why?
|
Obesity | 1 | 2017 | 12745 | 0.030 |
Why?
|
Social Control, Formal | 1 | 2015 | 110 | 0.030 |
Why?
|
Blood Glucose | 2 | 2022 | 6256 | 0.030 |
Why?
|
Risperidone | 1 | 2017 | 383 | 0.030 |
Why?
|
Critical Pathways | 1 | 2019 | 476 | 0.030 |
Why?
|
Criminals | 1 | 2015 | 62 | 0.030 |
Why?
|
Adolescent | 2 | 2019 | 85781 | 0.030 |
Why?
|
Diabetic Angiopathies | 1 | 2019 | 818 | 0.030 |
Why?
|
Prisons | 1 | 2015 | 161 | 0.030 |
Why?
|
Narcotic Antagonists | 1 | 2018 | 562 | 0.030 |
Why?
|
Internationality | 1 | 2018 | 1003 | 0.030 |
Why?
|
Blood Pressure | 2 | 2019 | 8554 | 0.030 |
Why?
|
Nigeria | 1 | 2015 | 733 | 0.030 |
Why?
|
Child | 1 | 2020 | 77709 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 25043 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2019 | 2715 | 0.030 |
Why?
|
Age of Onset | 1 | 2019 | 3271 | 0.030 |
Why?
|
Social Stigma | 1 | 2018 | 701 | 0.030 |
Why?
|
Syndrome | 1 | 2017 | 3251 | 0.020 |
Why?
|
Preventive Health Services | 1 | 2015 | 575 | 0.020 |
Why?
|
Buprenorphine | 1 | 2018 | 640 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2016 | 1125 | 0.020 |
Why?
|
Cysts | 1 | 2015 | 678 | 0.020 |
Why?
|
Psychotropic Drugs | 1 | 2015 | 894 | 0.020 |
Why?
|
Schools, Medical | 1 | 2015 | 880 | 0.020 |
Why?
|
Aged | 4 | 2022 | 163280 | 0.020 |
Why?
|
Health Promotion | 1 | 2019 | 2205 | 0.020 |
Why?
|
Insulin | 1 | 2022 | 6580 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2016 | 2278 | 0.020 |
Why?
|
Disease Management | 1 | 2016 | 2459 | 0.020 |
Why?
|
Medication Adherence | 1 | 2016 | 2063 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2018 | 3843 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 3923 | 0.010 |
Why?
|
Sex Factors | 1 | 2015 | 10397 | 0.010 |
Why?
|
Pregnancy | 1 | 2017 | 29144 | 0.010 |
Why?
|
United States | 1 | 2021 | 69872 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 35421 | 0.000 |
Why?
|